Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension

Phase 3 Completed 44 enrolled Viatris Inc.

Non-randomizedSingle-groupOpen-labelTreatment

Summary

To assess the safety of sildenafil 20 mg TID orally given to Japanese pulmonary arterial hypertension patients (Part 1 and 2) To assess the efficacy after 12 weeks of treatment of sildenafil 20 mg TID orally given to Japanese pulmonary arterial hypertension patients (Part 1)

Timeline

Start: 2007-04
Primary completion: 2009-02
Completion: 2009-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sildenafil	Unknown	20 mg	Oral

Open Label Study of Sildenafil in Patients With Pulmonary Arterial Hypertension

Summary

Timeline

Drugs

Indications